Henry Schein (Nasdaq: HSIC) + announced today that it made a strategic move to enter the extremities segment of the orthopedic market.
Melville, New York-based Henry Schein plans to enter into the upper and lower extremities market. To execute this strategy, the company signed an agreement to acquire a majority interest in TriMed. TriMed develops orthopedic solutions for the foot and ankle as well as hand and wrist markets.
According to a news release, the Santa Clarita, California-based company brought in sales of about $48 million in 2022. Henry Schein expects to complete the acquisition in the first quarter of 2024. It anticipates a neutral adjusted earnings per share impact in 2024 before an accretive impact thereafter.
On top of the TriMed acquisition, Henry Schein entered into a strategic relationship with Extremity Medical. The medical device company focuses on products for fusion, fixation and motion pre…